Aida Perramon Güell
Grado: Máster
2951/2943
aperramon(ELIMINAR)@irblleida.cat
Publicaciones
-
Ruiz-Mitjana, A; Vidal-Sabanés, M; Navaridas, R; Perramon-Güuell, A; Yeramian, A; Nicholson-Sabate, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X
Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-ß and p38/ERK MAPK signalling
BIOMEDICINE & PHARMACOTHERAPY 168 115817-115817. .
-
Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers
Advanced Science 10 -. .
-
Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Perramon-Güell A; Megino-Luque C; Llobet-Navas D; Matias-Guiu X; Egea J; Encinas M; Bardia L; Colombelli J; Dolcet X
Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.
Cancer Communications 43 620-624. .
Proyectos
- INVESTIGO 2022: Senyalització oncogènica i del desenvolupament
